| Nicole Decamp, MD | |
|
6201 N Santa Fe Ave, Suite 2015, Oklahoma City, OK 73118-7538 | |
| (405) 848-2800 | |
| Not Available |
| Full Name | Nicole Decamp |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 29 Years |
| Location | 6201 N Santa Fe Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942246475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 19832 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Anthony Hospital - Oklahoma City | Oklahoma city, OK | Hospital |
| Entity Name | Nicole Decamp, Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255455408 PECOS PAC ID: 0042479214 Enrollment ID: O20120307000338 |
News Archive
Callidus Software Inc., the leader in Sales Performance Management (SPM), today announced that Philips Healthcare has selected Callidus Monaco's Objective Management solution to develop and manage its sales force. Under the agreement, signed in the fourth quarter of 2009, Philips Healthcare will use Callidus' application to deploy and manage strategic sales objectives for its sales representatives in the United States.
Highmark Inc., which sells plans in Pennsylvania, Delaware and West Virginia, will stop covering power morcellation, a technique often used in hysterectomies, after the Food and Drug Administration advised doctors against it because it may spread cancer.
According to updated findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery continues to significantly improve disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutations.
The American College of Rheumatology today praised Representative Raul Ruiz, MD (D-CA) and Representative Brad Wenstrup, MD (R-OH) for introducing the "Safe Step Act" (H.R. 2279). If enacted, H.R. 2279 would place reasonable parameters around the use of step therapy among employer-sponsored health plans.
A new device has demonstrated it has the potential to enhance the viability of donor livers for transplantation. Results revealed today at The International Liver Congress 2015 show that the transportable machine perfusion (MP) Airdrive is able to effectively maintain the quality of livers derived from donation after circulatory death (DCD).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Decamp, MD Po Box 2382, Oklahoma City, OK 73101-2382 Ph: (405) 848-2800 | Nicole Decamp, MD 6201 N Santa Fe Ave, Suite 2015, Oklahoma City, OK 73118-7538 Ph: (405) 848-2800 |
News Archive
Callidus Software Inc., the leader in Sales Performance Management (SPM), today announced that Philips Healthcare has selected Callidus Monaco's Objective Management solution to develop and manage its sales force. Under the agreement, signed in the fourth quarter of 2009, Philips Healthcare will use Callidus' application to deploy and manage strategic sales objectives for its sales representatives in the United States.
Highmark Inc., which sells plans in Pennsylvania, Delaware and West Virginia, will stop covering power morcellation, a technique often used in hysterectomies, after the Food and Drug Administration advised doctors against it because it may spread cancer.
According to updated findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery continues to significantly improve disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutations.
The American College of Rheumatology today praised Representative Raul Ruiz, MD (D-CA) and Representative Brad Wenstrup, MD (R-OH) for introducing the "Safe Step Act" (H.R. 2279). If enacted, H.R. 2279 would place reasonable parameters around the use of step therapy among employer-sponsored health plans.
A new device has demonstrated it has the potential to enhance the viability of donor livers for transplantation. Results revealed today at The International Liver Congress 2015 show that the transportable machine perfusion (MP) Airdrive is able to effectively maintain the quality of livers derived from donation after circulatory death (DCD).
› Verified 8 days ago
Jason Matthew Hirshburg, M.D. PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: University Of Oklahoma Hsc - Dermatology, 619 N.e. 13th St, Oklahoma City, OK 73104 Phone: 405-271-4662 Fax: 405-271-4662 | |
Raymond L Cornelison, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3727 Nw 63rd St Ste 205, Oklahoma City, OK 73116 Phone: 405-608-4494 Fax: 405-608-4504 | |
Dr. Carlos Andres Garcia, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4805 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-1506 Fax: 405-636-1511 | |
Mark Stover Sullivan, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3366 Nw Expressway, Suite 720, Oklahoma City, OK 73112 Phone: 405-947-0676 Fax: 405-945-4876 | |
Dr. Brandon Rhinehart, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western, Ste 301, Oklahoma City, OK 73114 Phone: 405-947-6647 Fax: 405-948-6647 | |
Mark A Dawkins, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13174 N Macarthur Blvd, Oklahoma City, OK 73142 Phone: 405-721-5555 Fax: 405-470-7093 | |
James W Taira, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1211 N Shartel Ave, Suite 202, Oklahoma City, OK 73103 Phone: 405-235-7546 |